Magic mushroom therapy tested for easing cancer Patients' mental anguish
NCT ID NCT05220046
Summary
This small, early-stage study is testing whether a guided therapy session using psilocybin (the active compound in 'magic mushrooms') can help reduce severe depression, anxiety, and emotional distress in people with advanced, incurable gastrointestinal cancers. The study involves 24 patients who will receive preparatory counseling, a single supervised psilocybin session, and follow-up support. Researchers will measure changes in psychological distress and also observe a family member of each participant to understand the broader impact.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSYCHOLOGICAL DISTRESS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
Conditions
Explore the condition pages connected to this study.